Peter Molloy
Corporate Officer/Principal bei TRYPTAMINE THERAPEUTICS LIMITED
Profil
Peter R.
Molloy is the founder of Edison Group, Inc., Tarus Therapeutics, Inc., and Maxsa Group, Inc. He is currently the President & Chief Executive Officer at Maxsa Group, Inc. and a Director at Edison Global Ltd.
He is also a Non-Executive Director & Chief Business Officer at Tryptamine Therapeutics Ltd., a Member of CFA Society of the UK, and the Chief Business Officer at Tryp Therapeutics, Inc. Previously, he served as the Chief Executive Officer at Edison Investment Research, Inc. from 2012 to 2018.
He was also a Founding Director at Edison Investment Research Ltd.
Additionally, he held the position of Independent Director at Taronis Fuels, Inc. from 2019 to 2021 and worked as a Portfolio Manager at Hermes Investment Management Ltd.
Mr. Molloy completed his undergraduate degree at The University of Exeter.
Aktive Positionen von Peter Molloy
| Unternehmen | Position | Beginn |
|---|---|---|
| TRYPTAMINE THERAPEUTICS LIMITED | Corporate Officer/Principal | - |
Edison Global Ltd.
 Edison Global Ltd. Commercial Printing/FormsCommercial Services Edison Global Ltd. is a leading investor relations business that operates across major capital markets. The private company is based in London, UK and has subsidiaries in the United States, New Zealand, Germany, the United Kingdom, and Australia. The British company specializes in creating optimal valuations for client stocks through their intelligent strategic advice, equity research, investor marketing, and direct engagement. | Direktor/Vorstandsmitglied | - |
| Maxsa Group, Inc. | Vorstandsvorsitzender | 01.01.2019 |
Tarus Therapeutics, Inc.
 Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | Gründer | - |
CFA Society of the UK
 CFA Society of the UK Miscellaneous Commercial ServicesCommercial Services CFA Society of the UK is an association of investment professionals based in the UK. The British company was founded in an unspecified year. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Peter Molloy
| Unternehmen | Position | Ende |
|---|---|---|
| TARONIS FUELS, INC. | Direktor/Vorstandsmitglied | 31.12.2021 |
Edison Investment Research, Inc.
 Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Vorstandsvorsitzender | 01.09.2018 |
Hermes Investment Management Ltd.
 Hermes Investment Management Ltd. Investment ManagersFinance Hermes Investment Management Ltd. (HIML) is an asset management firm headquartered in London, UK. They are a subsidiary of Federated Hermes Ltd., ultimately held by Federated Hermes, Inc. (NYSE: FHI) in the US. In 1990, the firm was founded as PostTel, subsequently changing their name to PosTel Financial Asset Management Ltd. They changed their name to Hermes Investment Management Ltd. in 1995. HIML provides discretionary and non-discretionary investment management services to institutional clients. | Corporate Officer/Principal | - |
Edison Group, Inc.
 Edison Group, Inc. Miscellaneous Commercial ServicesCommercial Services Edison Group, Inc. provides technology analysis and business consulting services. Its services include advisory, competitive research, end to end modern marketing, and results and sample deliverables. The company was founded by Dan Spiner in 2005 and is headquartered in New York, NY. | Vorstandsvorsitzender | - |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Peter Molloy
| The University of Exeter | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TARONIS FUELS, INC. | Process Industries |
| Private Unternehmen | 9 |
|---|---|
Hermes Investment Management Ltd.
Hermes Investment Management Ltd. Investment ManagersFinance Hermes Investment Management Ltd. (HIML) is an asset management firm headquartered in London, UK. They are a subsidiary of Federated Hermes Ltd., ultimately held by Federated Hermes, Inc. (NYSE: FHI) in the US. In 1990, the firm was founded as PostTel, subsequently changing their name to PosTel Financial Asset Management Ltd. They changed their name to Hermes Investment Management Ltd. in 1995. HIML provides discretionary and non-discretionary investment management services to institutional clients. | Finance |
Edison Investment Research Ltd.
 Edison Investment Research Ltd. Investment ManagersFinance Edison Investment Research Ltd. (Edison) is an investment research, investor relations and consulting firm headquartered in London, UK. The firm was founded by Stephen Rogers and Fraser Thorne in 2003. They are a subsidiary of Edison Global Ltd. Edison provides investment research to international investors, advisors and stakeholders. | Finance |
CFA Society of the UK
CFA Society of the UK Miscellaneous Commercial ServicesCommercial Services CFA Society of the UK is an association of investment professionals based in the UK. The British company was founded in an unspecified year. | Commercial Services |
Edison Group, Inc.
Edison Group, Inc. Miscellaneous Commercial ServicesCommercial Services Edison Group, Inc. provides technology analysis and business consulting services. Its services include advisory, competitive research, end to end modern marketing, and results and sample deliverables. The company was founded by Dan Spiner in 2005 and is headquartered in New York, NY. | Commercial Services |
Edison Investment Research, Inc.
Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Finance |
Edison Global Ltd.
Edison Global Ltd. Commercial Printing/FormsCommercial Services Edison Global Ltd. is a leading investor relations business that operates across major capital markets. The private company is based in London, UK and has subsidiaries in the United States, New Zealand, Germany, the United Kingdom, and Australia. The British company specializes in creating optimal valuations for client stocks through their intelligent strategic advice, equity research, investor marketing, and direct engagement. | Commercial Services |
Tryp Therapeutics, Inc.
 Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tryp Therapeutics, Inc. is a pharmaceutical company, which engages in identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. The company was founded on September 24, 2019 and is headquartered in Kelowna, Canada. | Health Technology |
| Maxsa Group, Inc. | |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | Health Technology |
